US-based pharmaceutical company Athenex, in partnership with the State University of New York Polytechnic Institute (SUNY Polytechnic Institute), is building a high pharmacy oncology manufacturing facility in Dunkirk, New York, to manufacture sterile high-potency oncology drugs.
Federal Equipment Company is a specialist supplier of pharmaceutical, chemical, and packaging machinery. With more than 15,000 items of equipment in stock and ready-to-ship from more than 600,000ft³ of warehouse space in Ohio, US, we are one of the largest suppliers of used process and packaging equipment in the world.
For more than 50 years, we have been the trusted name in the pharmaceutical processing equipment industry. We routinely deliver quality used components and machinery, consistently outstanding service, and highly competitive prices that meet the needs of our global customers. In addition, we maintain a strategic relationship with Pfizer Inc, which provides us with high-quality stock that includes process and packaging equipment at the forefront of the market.
Comprehensive machinery for pharmaceutical packaging production
Our pharmaceutical inventory is comprehensive enough to meet the equipment needs of the following manufacturing industries:
- Generic drugs
- Pharmaceutical contract manufacturing organizations (CMOs)
- Nutraceuticals and supplements
- Cosmetics and fragrances
- Biopharmaceuticals and biosimilars
- Foods and candies
Federal Equipment’s inventory is a one-stop-shop for manufacturing equipment.
Federal Equipment Company
We stock all of the equipment required to set-up a complete manufacturing operation for the following products and packaging:
- Solid doses: tablets, soft capsules, hard capsules, pellets and powders
- Liquid doses: solutions, suspensions, emulsions
- Semi-solids: creams, ointments and lotions
- Transdermal patches
- Aseptic fill and finish: vials, ampules, syringes, blow-fill-seal and sachets
- Primary packaging: blisters, bottles, pouches, bags, flow-wraps, tubes
- Secondary packaging: carton, shrink-wrap, trays, casepacks, taping, labelling, neckbands, cottoners
Sourcing process and packaging equipment
Federal Equipment’s inventory changes daily. Users can review our inventory at our website or call a sales associate for assistance. If you do not see the equipment you need, please let us know. Even if we do not have it in our current inventory, we can use our extensive network to help source your next piece of process or packaging equipment.
Investment recovery for packaging equipment and manufacturing facilities
Federal Equipment also offers a wide array of unique services, including the liquidation and auction of process lines and manufacturing facilities, as well as equipment appraisals.
With our extensive buying and selling experience, purchasing power, and global marketing reach, coupled with our extensive experience in various specialized markets, we can ensure our customers maximize their investment recovery efforts regardless of the size, location, or complexity of the project. We consistently provide value-added strategies that advance our client’s investment recovery goals and optimize profitability.
For example, Federal Equipment Company provides investment recovery services to one of the world’s largest and best-known pharmaceutical manufacturers, Pfizer. We are actively engaged at more than 30 Pfizer sites worldwide, evaluating and removing surplus process and packaging equipment for sale to interested parties or for redeployment within Pfizer’s own network.
Our current inventory of equipment includes surplus assets from Pfizer’s pharmaceutical plants, research and development facilities, and pilot plants, as well as kilo-plants, chemical plants, and API (active pharmaceutical ingredients) and pharmaceutical manufacturing plants.
You can view Pfizer-owned equipment at our website’s Pfizer Landing Page. Visit the site to view some of the highest quality pharmaceutical process and packaging equipment available globally.
Our clients save millions of dollars by purchasing high-quality surplus equipment from manufacturing leaders without forgoing quality.
In addition, we have a dedicated pharmaceutical building that satisfies the unique storage requirements of pharmaceutical equipment. Visit us and see all our pharmaceutical equipment under one roof.
Value, experience and service make Federal Equipment the right choice for the smart equipment buyer or seller.
Cost-effective used equipment for pharmaceutical manufacturers
Within the pharmaceutical industry, it is understood that the loss of a patent for a branded pharmaceutical leads to opportunities for contract manufacturing organizations (CMO) and generic pharmaceutical manufacturers. These manufacturers will often gear up quickly to produce lower margin copies.
This can leave pharmaceutical manufacturers with a surplus of manufacturing equipment, with much of it valuable to generic manufacturers and contract manufacturing organizations (CMO). With a reputable used equipment dealer, the branded manufacturer, CMOs, and generic manufacturers can all realize cost savings. Since the investment in new pharmaceutical equipment remains a large and complex commitment for any manufacturing facility, recovering a portion of that capital investment in equipment is vital.
Project managers often opt to work with a used equipment dealer such as us to evaluate and appraise the equipment. CMOs and generic manufacturers have the opportunity to view and evaluate this equipment for their needs. Used equipment is generally a fraction of the price of new equipment and is available immediately. Engaging with a used equipment dealer provides the opportunity for significant cost savings and the ability to obtain high-quality equipment in a short space of time.
In June 2017, US-based biopharmaceutical company Pfizer began building a research and development (R&D) laboratory and office facility in Chesterfield, Missouri.
Iceland-based biopharmaceutical company Alvotech officially opened a biosimilar facility in Reykjavik on 8 June 2016. The facility will be dedicated to the production of biosimilars of monoclonal antibodies (mAbs).